Predicted clinical and economic burden associated with reduction in access to acute coronary interventional care during the COVID-19 lockdown in two European countries.
Mattia LunardiMamas A MamasJosepa MauriCarmen Medina MolinaOriol Rodriguez-LeorSimon EggingtonJan B PietzschNatalie L PapoSilke Walleser-AutieroAndreas BaumbachFrancesco MaisanoFlavio L RibichiniDarren MylotteEmanuele BarbatoJan J PiekWilliam WijnsChristoph K Nabernull nullPublished in: European heart journal. Quality of care & clinical outcomes (2023)
The effect of a 1-month lockdown on STEMI treatment led to a reduction in survival and QALYs compared to the pre-pandemic era. Moreover, in working-age patients, untimely revascularization led to adverse prognosis, affecting societal productivity and therefore considerably increasing societal costs.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- ejection fraction
- healthcare
- percutaneous coronary intervention
- newly diagnosed
- coronary artery
- liver failure
- climate change
- coronary artery disease
- palliative care
- heart failure
- intensive care unit
- peritoneal dialysis
- prognostic factors
- coronary artery bypass grafting
- hepatitis b virus
- st elevation myocardial infarction
- emergency department
- aortic dissection
- patient reported outcomes
- patient reported
- chronic pain
- atrial fibrillation